Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Apr 6, 2023
- Accession no.
- 0001773751-23-000112
- Filed
- Apr 6, 2023
- Trade date
- Apr 4-5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $300.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | Class A Common Stock | SSaleDisposed | −11,299 | $10.09F2 | −$114,006.91 | 464,544 | Direct | |
| Apr 4, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $10.06F3 | −$91,877.98 | 455,411 | Direct | |
| Apr 5, 2023 | Class A Common Stock | SSaleDisposed | −500 | $10.04F4 | −$5,020 | 454,911 | Direct | |
| Apr 5, 2023 | Class A Common Stock | SSaleDisposed | −9,133 | $9.82 | −$89,686.06 | 445,778 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.00 - $10.275. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.86 - $10.28. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $10.015 - $10.085. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.